Advertisement
Research Article

Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition

  • Christopher J. Vavricka equal contributor,

    equal contributor Contributed equally to this work with: Christopher J. Vavricka, Qing Li, Yan Wu

    Affiliation: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China

    X
  • Qing Li equal contributor,

    equal contributor Contributed equally to this work with: Christopher J. Vavricka, Qing Li, Yan Wu

    Affiliations: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China, School of Life Sciences, University of Science and Technology of China, Hefei, China

    X
  • Yan Wu equal contributor,

    equal contributor Contributed equally to this work with: Christopher J. Vavricka, Qing Li, Yan Wu

    Affiliation: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China

    X
  • Jianxun Qi,

    Affiliation: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China

    X
  • Mingyang Wang,

    Affiliations: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China, Graduate University, Chinese Academy of Sciences, Beijing, China

    X
  • Yue Liu,

    Affiliation: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China

    X
  • Feng Gao,

    Affiliation: National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China

    X
  • Jun Liu,

    Affiliation: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China

    X
  • Enguang Feng,

    Affiliation: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China

    X
  • Jianhua He,

    Affiliation: Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, China

    X
  • Jinfang Wang,

    Affiliation: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China

    X
  • Hong Liu,

    Affiliation: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China

    X
  • Hualiang Jiang,

    Affiliation: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China

    X
  • George F. Gao mail

    gaof@im.ac.cn

    Affiliations: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China, School of Life Sciences, University of Science and Technology of China, Hefei, China, Graduate University, Chinese Academy of Sciences, Beijing, China, Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China

    X
  • Published: October 20, 2011
  • DOI: 10.1371/journal.ppat.1002249

Reader Comments (1)

Post a new comment on this article

Clarification

Posted by cvavricka on 24 Oct 2011 at 07:18 GMT

George F Gao is a leading principal investigator of the National Natural Science Foundation of China (NSFC) Innovative Research Group (Grant 81021003). The active form of oseltamivir, oseltamivir carboxylate, is displayed in Figure 1 and was used for the inhibition assays.

No competing interests declared.